Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov;19(2):60-68.
doi: 10.17925/EE.2023.19.2.9. Epub 2023 Aug 31.

Are Prepubertal Gynaecomastia and Premature Thelarche Linked to Topical Lavender and Tea Tree Oil Use?

Affiliations
Review

Are Prepubertal Gynaecomastia and Premature Thelarche Linked to Topical Lavender and Tea Tree Oil Use?

Elsa W Braunstein et al. touchREV Endocrinol. 2023 Nov.

Abstract

Various studies, conducted since 2007, have reported a total of eight boys with prepubertal gynaecomastia and four girls with premature thelarche following exposure to lavender and/or tree tea oil. All patients experienced regression of the breast tissue after they stopped using these oils. Both of these essential oils, and several of their constituents, have oestrogenic and antiandrogenic activity in vitro. However, limited dermal penetration of some of the components means that the in vitro findings cannot be extrapolated to the in vivo situation. There are unanswered questions as to how much lavender or tea tree oil was actually present in the skincare products used by the children and a lack of information about exposure to other agents. Furthermore, since both prepubertal gynaecomastia and premature thelarche often spontaneously regress, it cannot be concluded that the use of lavender and/or tree tea oil is the cause of the gynaecomastia and thelarche in these children.

Keywords: Gynaecomastia; endocrine disrupting chemicals; essential oils; lavender oil; premature thelarche; tea tree oil.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Glenn Braunstein has been a defence expert for Johnson & Johnson in litigation involving risperidone allegedly causing gynaecomastia. Elsa Braunstein has no financial or non-financial relationships or activities to declare in relation to this article.

References

    1. Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007;356:479–85. doi: 10.1056/NEJMoa064725. - DOI - PubMed
    1. Ramsey JT, Li Y, Arao Y. et al. Lavender products associated with premature thelarche and prepubertal gynecomastia: Case reports and endocrine-disrupting chemical activities. J Clin Endocrinol Metab. 2019;104:5393–405. doi: 10.1210/jc.2018-01880. - DOI - PMC - PubMed
    1. Gore AC, Chappell VA, Fenton SE. et al. EDC-2: The endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36:E1–150. doi: 10.1210/er.2015-1010. - DOI - PMC - PubMed
    1. Braunstein GD. Environmental gynecomastia. Endocr Pract. 2008;14:409–11. doi: 10.4158/EP.14.4.409. - DOI - PubMed
    1. Einav-Bachar R, Phillip M, Aurbach-Klipper Y, Lazar L. Prepubertal gynaecomastia: Aetiology, course, and outcome. Clin Endocrinol (Oxf). 2004;61:55–60. doi: 10.1111/j.1365-2265.2004.02059.x. - DOI - PubMed

LinkOut - more resources